This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

ARIAD Pharmaceuticals Inc (ARIA)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 237.18M 119.38M 306.26M 103.63M
Receivables 1.30M 101.00K 34.00K 407.00K
Inventories 419.00K 0.00 0.00 0.00
Other Current Assets 6.04M 3.84M 1.28M 1.14M
Total Current Assets 244.95M 168.35M 307.57M 105.17M
Property, Plant & Equipment, Gross 149.09M 43.90M 39.98M 37.76M
Accumulated Depreciation & Depletion 40.31M 36.22M 33.37M 30.73M
Property, Plant & Equipment, Net 108.78M 7.68M 6.61M 7.04M
Intangibles 968.00K 3.12M 5.74M 7.07M
Other Non-Current Assets 16.20M 1.04M 791.00K 749.00K
Total Non-Current Assets 125.95M 11.84M 13.14M 14.86M
Liabilities & Shareholder Equity
Total Assets 370.89M 180.19M 320.71M 120.03M
Accounts Payable 15.54M 8.27M 5.73M 3.12M
Short Term Debt 4.20M 2.12M 1.45M 1.47M
Other Current Liabilities 10.96M 698.00K 1.17M 829.00K
Total Current Liabilities 72.18M 48.87M 25.37M 16.40M
Long Term Debt 4.90M 9.10M 11.22M 8.29M
Deferred Income Taxes 0.00 0.00 2.72M 2.12M
Other Non-Current Liabilities 8.89M 9.38M 61.26M 29.14M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 113.20M 18.48M 75.20M 39.56M
Total Liabilities 185.38M 67.34M 100.57M 55.95M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 185.52M 112.85M 220.14M 64.08M
Common Par 186.00K 167.00K 158.00K 127.00K
Additional Paid In Capital 1.24B 890.50M 776.95M 497.31M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -1.05B -777.84M -556.96M -433.36M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -1.54M 20.00K 0.00 0.00
Total Capitalization 190.42M 121.95M 231.36M 72.37M
Total Equity 185.52M 112.85M 220.14M 64.08M
Total Liabilities & Stock Equity 370.89M 180.19M 320.71M 120.03M
Total Common Shares Outstanding 185.90M 167.08M 157.61M 126.94M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 183.58M 164.96M 132.38M 113.02M
Diluted Weighted Shares Outstanding 183.58M 164.96M 132.38M 114.73M
Number of Employees 307 300 150 122
Number of Part-Time Employees 0 0 0 0

ARIA ARIAD Pharmaceuticals Inc

Analysts Ratings for ARIA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 5
Moderate Buy 0 0 0 0
Hold 4 4 4 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

ARIA Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs